NHAS
Novo Holdings A/S Portfolio holdings
AUM
$1.29B
1-Year Est. Return
46.37%
This Fund
S&P 500
1 Year Est. Return
+46.37%
AUM
$1.29B
AUM Growth
-$264M
(-17%)
Holding
28
Top Buys
| 1 | +$61.8M | |
| 2 | +$16.7M | |
| 3 | +$4.41M | |
| 4 |
Enliven Therapeutics
ELVN
|
+$1.07M |
Top Sells
| 1 | +$341M | |
| 2 | +$70.6M | |
| 3 | +$38.7M | |
| 4 |
ASML
ASML
|
+$33.3M |
| 5 |
ZBIO
Zenas BioPharma
ZBIO
|
+$18.1M |
Sector Composition
| 1 | Healthcare | 68.02% |
| 2 | Technology | 16.42% |
| 3 | Financials | 12.46% |
| 4 | Consumer Discretionary | 2.93% |
| 5 | Industrials | 0.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRUS
26
DELISTED
Merus
MRUS
| – | – |
-750,000
|
|
||
27
Recursion Pharmaceuticals
RXRX
$1.79B
| – | – |
-7,929,835
|
|
||
28
Vanguard Total Stock Market ETF
VTI
$570B
| – | – |
-1,038,550
|
|